Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The metabolic syndrome.

T Fulop1, D Tessier, A Carpentier

  • 1Research Centre on Aging, Immunology Graduate Programme, Faculty of Medicine, University of Sherbrooke, 1036, rue Belvedere Sud, Sherbrooke, Que., Canada J1H 4C4. tamas.fulop@usherbrooke.ca

Pathologie-Biologie
|August 15, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dose distribution of the brain tissue associated with cognitive functions in high-grade glioma patients.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2020
Same author

Cylindroma spine metastasis: Long-term follow-up is required.

Neuro-Chirurgie·2019
Same author

Whole brain radiotherapy with concurrent temozolomide in multifocal and/or multicentric newly diagnosed glioblastoma.

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia·2019
Same author

Recipients with blood group A associated with longer survival rates in cardiac valvular bioprostheses.

EBioMedicine·2019
Same author

The Cape Town Declaration on Access to Cardiac Surgery in the Developing World.

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·2018
Same author

Prehospital triage of septic patients at the SAMU regulation: Comparison of qSOFA, MRST, MEWS and PRESEP scores.

The American journal of emergency medicine·2017

Metabolic syndrome (MS), characterized by obesity and insulin resistance (IR), is an epidemic increasing cardiovascular disease and type 2 diabetes risk. Lifestyle changes and medications targeting inflammation are key treatments.

Area of Science:

  • Endocrinology
  • Cardiovascular Medicine
  • Metabolic Health

Background:

  • Metabolic syndrome (MS) is a growing epidemic linked to increased cardiovascular disease and type 2 diabetes.
  • Visceral obesity and insulin resistance (IR) are primary drivers of MS development.
  • Low-grade inflammation from abdominal obesity contributes to IR and MS pathogenesis.

Purpose of the Study:

  • To review the role of inflammation in metabolic syndrome.
  • To discuss current treatment strategies for MS.
  • To highlight the need for novel therapeutic approaches.

Main Methods:

  • Literature review of clinical studies on metabolic syndrome.
  • Analysis of the relationship between obesity, inflammation, and insulin resistance.

Related Experiment Videos

  • Examination of current treatment modalities and their anti-inflammatory effects.

    • Main Results:

    • Increased C-reactive protein (CRP) correlates with MS components in obese individuals.
    • Inflammation interferes with insulin signaling, contributing to MS.
    • Lifestyle interventions (diet, exercise) and medications can improve IR and inflammation.

    Conclusions:

    • Metabolic syndrome poses a significant public health challenge due to rising prevalence.
    • Targeting inflammation alongside IR is crucial for effective MS management.
    • Further research is essential for developing new therapies to reduce MS incidence and improve quality of life.